July 20, 2021 – BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) announced it has taken a large step forward in transforming the patient experience through a vision of a “One-Stick Hospital Stay.”
With the recent acquisition of Velano Vascular (San Francisco, CA) and its needle-free technology that enables high-quality blood draws from existing peripheral intravenous catheter (PIVC) lines, BD says it can now enable healthcare providers to help eliminate multiple needlesticks for blood sample collection.
The addition of Velano Vascular’s FDA-cleared PIVO device allows BD to help healthcare providers move closer to the aspirational vision of the “One-Stick Hospital Stay,” where certain low-acuity patients will only have one “stick” for their entire hospital stay.
“As a global leader in vascular access solutions and blood collection, BD has been on the forefront of innovations that improve the patient experience and reduce additional needlesticks,” said Rick Byrd, president of Medication Delivery Solutions for BD. “Now, with the addition of Velano and its groundbreaking technologies, we can envision a world where a ‘One-Stick Hospital Stay’ could be a reality for many by making the numerous inpatient blood draws better for everyone.”
BD says the Velano acquisition is consistent with the company’s growth strategy to enter new categories that address unmet needs and deliver higher impact to patients and health systems. Terms of the transaction were not disclosed.